Monte Rosa Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Monte Rosa Therapeutics has filed a definitive proxy statement with the SEC regarding its upcoming shareholder meeting.
NASDAQ
Monte Rosa Therapeutics will hold its 2025 Annual Meeting of Stockholders virtually on June 13, 2025, to elect directors and ratify the appointment of its independent accounting firm.
NASDAQ
Monte Rosa Therapeutics has filed a definitive proxy statement with the SEC.
NASDAQ
Monte Rosa Therapeutics will hold its 2024 Annual Meeting of Stockholders virtually on June 12, 2024, to elect directors and ratify the appointment of its independent accounting firm.